title: Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
authors.forename: Sebastian Benedikt
authors.initials: SB
authors.lastname: Röhr
authors.forename: Harald
authors.initials: H
authors.lastname: Sauer
authors.forename: Ludwig
authors.initials: L
authors.lastname: Gortner
authors.forename: Stefan
authors.initials: S
authors.lastname: Gräber
authors.forename: Sascha
authors.initials: S
authors.lastname: Meyer
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002312:Cardiomyopathy, Hypertrophic / Q000139:chemically induced; D003907:Dexamethasone / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects* / Q000627:therapeutic use; D006943:Hyperglycemia / Q000139:chemically induced; D006955:Hypernatremia / Q000139:chemically induced; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000139:chemically induced* / Q000188:drug therapy; D019102:Infant, Very Low Birth Weight; D008297:Male; D011446:Prospective Studies; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy; D013927:Thrombosis / Q000139:chemically induced; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D006854:Hydrocortisone